Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study for Evaluating the Safety and Performance of CSF-3 ECG Lead-I, HR and PR When Compared to ECG Holter

NCT05591157 is registered in ClinicalTrials.gov with CardiacSense Ltd. as lead sponsor.

NCT NCT05591157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05591157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study for Evaluating the Safety and Performance of CSF-3 ECG Lead-I, HR and PR When Compared to ECG Holter
Lead sponsor
CardiacSense Ltd.
Phase
Not applicable
Overall status
Completed
Start date
November 16, 2022
Completion date
February 1, 2023
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ecg, healthy